CASC3 and Miyoshi myopathy: Proteasome inhibitors bortezomib (BTZ), carfilzomib, and ixazomib significantly suppressed the proliferation of SP cells in MM patient cells and MM cell lines, and metformin enhances the anti-SP effect of BTZ.